Bronchoscope market seen topping $6 billion by 2030

The global bronchoscope market is projected to exceed $6 billion in 2030, led by North America and the U.S. and driven by rising respiratory disease cases, hospital investment and new imaging technologies. Flexible bronchoscopes are expected to remain the largest product segment as demand shifts toward minimally invasive and single-use tools.

Why it matters: - The bronchoscope market is moving alongside rising demand for earlier lung disease diagnosis and minimally invasive pulmonary procedures. - The category is projected to cross $6 billion by 2030, making it a meaningful slice of the broader medical equipment market. - Growth in disposable devices, high-definition imaging and robotic bronchoscopy could reshape how respiratory care is delivered in hospitals and outpatient settings.

What happened: - The Business Research Company released a bronchoscope market outlook covering 2026-2035. - The report estimates the bronchoscope market will surpass $6 billion in 2030. - The market is projected to grow at a 12% compound annual growth rate leading up to 2030. - The broader medical equipment industry is expected to reach $1,176 billion by 2030, with bronchoscopy accounting for nearly 0.5% of total value. - North America is expected to be the largest region in 2030, with a market value of $1.8 billion. - The U.S. is projected to be the largest country in the market in 2030, at $1.6 billion. - Request a free sample of the report. - Access the detailed report.

The details: - North America is expected to grow from $1.1 billion in 2025 to $1.8 billion in 2030, at a 10% CAGR. - The report ties North America’s growth to higher rates of lung cancer, COPD and asthma, plus stronger reimbursement and hospital investment in pulmonary care. - The U.S. market is expected to rise from $1.0 billion in 2025 to $1.6 billion in 2030, also at a 10% CAGR. - U.S. growth is linked to more bronchoscopy procedures for early lung disease detection, stronger manufacturer presence, wider use of disposable bronchoscopes and more advanced imaging and robotic platforms. - Flexible bronchoscopes are expected to be the largest product segment in 2030, representing 63% of the market, or about $4 billion. - Rigid bronchoscopes and flexible bronchoscopes are projected to be the biggest growth opportunities, with each segment expected to add about $1 billion between 2025 and 2030. - The market is also segmented by usability into reusable and disposable bronchoscopes, by application into diagnosis and treatments, and by end user into hospitals, clinics, ambulatory surgical centers and other users. - The report points to three main demand drivers: the burden of respiratory disease and lung cancer, hospital investment in bronchoscopy suites and advances in optics and imaging. - Respiratory disease and lung cancer are projected to contribute about 2.9% annual growth to the market. - Hospital investment in bronchoscopy suites is projected to contribute about 2.1% annual growth. - Technological advances in optics and imaging are projected to contribute about 1.9% annual growth. - New additions to the 2026 report set include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspot infographics, key technology analysis, future trend analysis and updated graphics and tables.

Between the lines: - The report suggests the market is being pulled by two forces at once: more patients who need respiratory diagnostics and better tools that make procedures easier and safer. - Disposable and single-use bronchoscopes appear to be gaining traction because they address infection control and cross-contamination concerns. - The emphasis on robotic-assisted systems and advanced imaging signals a market shifting toward higher-precision pulmonary care rather than basic airway visualization. - The report includes a disclaimer that its findings, conclusions and recommendations are estimates and opinions, not statements of fact or investment guidance. - The Business Research Company says it has published more than 30,000 reports across 27 industries and 60 geographies, using 1,500,000 datasets plus secondary research and interviews with industry leaders.

What's next: - The report expects demand to keep building through 2030 as hospitals expand pulmonary infrastructure and clinicians adopt more advanced bronchoscopy platforms. - Flexible and rigid bronchoscope segments are positioned to remain key growth areas as minimally invasive respiratory care spreads. - Continued adoption of single-use, portable and robotic-assisted systems could further support market expansion if infection prevention and procedural efficiency remain priorities.

The bottom line: - Bronchoscopy is shifting from a niche diagnostic tool to a faster-growing, technology-driven segment of respiratory care, with North America and the U.S. set to lead the market through 2030.